Oppenheimer Reiterates Outperform on NuCana, Maintains $4 Price Target
Portfolio Pulse from richadhand@benzinga.com
Oppenheimer analyst Leland Gershell reiterated an Outperform rating on NuCana (NASDAQ:NCNA) and maintained a $4 price target.
May 22, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Leland Gershell reiterated an Outperform rating on NuCana and maintained a $4 price target.
The news directly mentions NuCana (NASDAQ:NCNA) and the analyst's reiteration of an Outperform rating and maintaining a $4 price target indicates a positive outlook for the stock. This could lead to a short-term increase in the stock price as investors may view this as a positive signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100